Christopher A. Walsh, MD, PhD

Chief, Division of Genetics, Pediatrics, Boston Children's Hospital; Investigator, Howard Hughes Medical Institute; Bullard Professor of Pediatrics and Neurology, Harvard Medical School.

Research Focus
Development, evolution and function of the human cerebral cortex.
Brief Research Description
Dr. Walsh's lab studies the normal development of the human cerebral cortex, as well as identifying mutations that disrupt the normal development and function of the human cerebral cortex. They focus on Mendelian pediatric brain diseases, manifesting as autism, epilepsy, intellectual disability and other learning disorders. Not only are these genes vital for the normal development of the cortex, but also some have been altered evolutionarily to allow the unique aspects of the brain that underlie human cognitive abilities. Therefore these genes define in some sense what makes us uniquely human. They have identified more than two-dozen human disease genes. Most of their genetic work has benefited from worldwide collaborations, especially in Middle Eastern countries where consanguinity is common, since this enhances the effects of recessive mutations and makes them easier to map and identify. Recent work has focused notably on the role of somatic mutations in neurological disease. This has led to the characterization of somatic mutations in AKT3, MTOR, and PIK3CA that result in hemimegalencephaly (enlarged, malformed cerebral hemisphere) and focal cortical dysplasia, and they are also studying the role of somatic mutation in autism and other developmental disorders. They have pioneered “single cell genomics” at both the RNA level--to study brain progenitor cells--and at the DNA level, and have discovered that the somatic mutations that occur in dividing progenitor cells during normal human brain development cause adult human neurons to bear indelible marks of the pattern of cell divisions that produce the human brain.
Key Publications (PMCIDs)

Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size.
Johnson MB, Sun X, Kodani A, Borges-Monroy R, Girskis KM, Ryu SC, Wang PP, Patel K, Gonzalez DM, Woo YM, Yan Z, Liang B, Smith RS, Chatterjee M, Coman D, Papademetris X, Staib LH, Hyder F, Mandeville JB, Grant PE, Im K, Kwak H, Engelhardt JF, Walsh CA, Bae BI.
Nature 2018;556(7701):370-5. PMCID: PMC6095461

Aging and neurodegeneration are associated with increased mutations in single human neurons.
Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, Sherman MA, Vitzthum CM, Luquette LJ, Yandava CN, Yang P, Chittenden TW, Hatem NE, Ryu SC, Woodworth MB, Park PJ, Walsh CA.
Science 2018;359(6375):555-9. PMCID: PMC5831169

Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder.
Lim ET, Uddin M, De Rubeis S, Chan Y, Kamumbu AS, Zhang X, D'Gama AM, Kim SN, Hill RS, Goldberg AP, Poultney C, Minshew NJ, Kushima I, Aleksic B, Ozaki N, Parellada M, Arango C, Penzol MJ, Carracedo A, Kolevzon A, Hultman CM, Weiss LA, Fromer M, Chiocchetti AG, Freitag CM, Autism Sequencing Consortium, Church GM, Scherer SW, Buxbaum JD, Walsh CA.
Nat Neurosci 2017;20(9):1217-24. PMCID: PMC5672813